Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the European Union based on earlier trial readouts. Outside of Japan and the UAE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback